| Cancer pain assessment and classification A Caraceni, M Shkodra Cancers 11 (4), 510, 2019 | 238 | 2019 |
| Neuropathic pain: clinical classification and assessment in patients with pain due to cancer M Shkodra, C Brunelli, E Zecca, F Formaglio, P Bracchi, SL Dico, ... Pain 162 (3), 866-874, 2021 | 33 | 2021 |
| Treatment of neuropathic pain directly due to cancer: an update M Shkodra, A Caraceni Cancers 14 (8), 1992, 2022 | 26 | 2022 |
| Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts S Stacchiotti, HR Dürr, IM Schaefer, K Woertler, R Haas, A Trama, ... Cancer treatment reviews 112, 102491, 2023 | 23 | 2023 |
| Telemedicine for outpatient palliative care during COVID-19 pandemics: a longitudinal study A Caraceni, C Pellegrini, M Shkodra, E Zecca, P Bracchi, SL Dico, ... BMJ Supportive & Palliative Care 14 (e1), e1201-e1207, 2024 | 11 | 2024 |
| Cancer pain: Results of a prospective study on prognostic indicators of pain intensity including pain syndromes assessment M Shkodra, C Brunelli, E Zecca, G Infante, R Miceli, M Caputo, P Bracchi, ... Palliative medicine 36 (9), 1396-1407, 2022 | 7 | 2022 |
| Cancer pain assessment and classification. Cancers (Basel) 11 (4) A Caraceni, M Shkodra | 6 | 2019 |
| A real‐world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab P Bracchi, E Zecca, C Brunelli, R Miceli, G Tinè, M Maniezzo, S Lo Dico, ... Cancer Medicine 12 (17), 18317-18326, 2023 | 2 | 2023 |
| Anticancer Drugs-Related Hypogonadism in Male Patients with Advanced Cancers on Active Treatment: A Systematic Review G Massa, L Zambelli, E Zecca, M Shkodra, G Tinè, A Caraceni The Oncologist 29 (6), e728-e740, 2024 | 1 | 2024 |
| Application and accuracy of the EAPC/IASP diagnostic algorithm for neuropathic cancer pain and quantitative sensory testing profile in patients with pain due to cancer M Shkodra, M Mulvey, M Fallon, C Brunelli, E Zecca, P Bracchi, M Caputo, ... Pain Reports 9 (2), e1140, 2024 | | 2024 |
| A European pharmacogenomic study of the response to opioids in advanced cancer patients identifies germline variants associated with nausea-vomiting side effect F Minnai, M Shkodra, S Noci, C Brunelli, A Pigni, E Zecca, F Skorpen, ... | | 2024 |
| Clinical assessment of cancer pain patients: focus on Neuropathic Pain M Shkodra | | 2024 |
| An European pharmacogenomic study of response to opioids in advanced cancer patients identified variants associated with efficacy and toxicity F Minnai, M Shkodra, S Noci, C Brunelli, A Pigni, F Skorpen, P Klepstad, ... EUROPEAN JOURNAL OF HUMAN GENETICS 32, 687-688, 2024 | | 2024 |
| Prognostic Indicators of Survival M Shkodra, AT Caraceni, M Maltoni, C Modonesi Textbook of Palliative Medicine and Supportive Care, 705-716, 2021 | | 2021 |
| Pain in oncological patient: Concordance between DN4 and clinical evaluation M Shkodra, C Brunelli, E Zecca, F Formaglio, P Bracchi, S Lo Dico, ... JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 25 (4), 552-552, 2020 | | 2020 |
| Genome-wide association studies of advanced cancer patients identified loci associated with opioid-induced nausea-vomiting F Minnai, M Shkodra, S Noci, C Brunelli, A Pigni, F Skorpen, P Klepstad, ... BLENDING BIOLOGY AND BIOINFORMATICS, 48, 0 | | |
